Oxidative Medicine and Cellular Longevity

About this Journal

Aims and scope

Oxidative Medicine and Cellular Longevity is a unique peer-reviewed journal that publishes original research and review articles dealing with the cellular and molecular pathophysiological mechanisms of oxidants in health and disease. Oxidative processes influence almost all acute and chronic progressive disorders and on a cellular basis is intimately linked to cell signaling, metabolism, immune function, and senescence. The journal is an important source of information and knowledge in today’s cancer, cardiovascular, immunology, and neuroscience scientific literature and serves as an international forum for the scientific community worldwide to translate pioneering “bench to bedside” research into clinical strategies.

Topics of interest include:

  • Aging
  • Cancer
  • Metabolism
  • Immune Function
  • Cardiovascular Disease and Vascular Biology
  • Neurological Disease and Neurodegeneration

    Bibliographic information

    ISSN: 1942-0900 (Print)
    ISSN: 1942-0994 (Online)
    DOI: 10.1155/2572


      Oxidative Medicine and Cellular Longevity was founded in 2008 by Professor Kenneth Maiese who served as the Editor-in-Chief of the journal between 2008 and 2011.

        Open Access

        Oxidative Medicine and Cellular Longevity is an open access journal. All articles are immediately available to read and reuse upon publication. More information about our Open Access policy can be found on our copyright page.


          Editorial enquiries should be directed to [email protected].

          General enquiries should be directed to [email protected].


            Oxidative Medicine and Cellular Longevity
             Journal metrics
            See full report
            Acceptance rate25%
            Submission to final decision79 days
            Acceptance to publication25 days
            Journal Citation Indicator-
            Impact Factor-

            Article of the Year Award: Outstanding research contributions of 2021, as selected by our Chief Editors. Read the winning articles.